"Designing Growth Strategies is in our DNA"

U.S. Biosimilars Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, and Others), By Disease Indication (Cancer, Autoimmune Diseases {Arthritis, Psoriasis, Neutropenia, and Others}, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2022-2029

Region : United States | Format: PDF | Report ID: FBI100990

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Inquire Before Buying

Refresh Button
Booklet
  • May, 2022
  • 2021
  • 2018-2020
  • 105

    CHOOSE LICENSE TYPE

  • $2850
    $3850
    $5850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X